The DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index.
A Comparison of Biochemical Tests for Pheochromocytoma: Measurement of Fractionated Plasma Metanephrines Compared with the Combination of 24-Hour Urinary Metanephrines and Catecholamines
Abstract
We compared the diagnostic efficacy of fractionated plasma metanephrine measurements to measurements of 24-h urinary total metanephrines and catecholamines in outpatients tested for pheochromocytoma at Mayo Clinic Rochester from January 1, 1999, until November 27, 2000. Catecholaminesecreting tumors were histologically proven. The sensitivity of fractionated plasma metanephrines was 97% (30 of 31 patients), compared with a sensitivity of 90% (28 of 31) for urinary total metanephrines and catecholamines (P = 0.63). The specificity of fractionated plasma metanephrines was 85% (221 of 261), compared with 98% (257 of 261; P < 0.001) for urinary measurements. The likelihood ratios for positive tests were 6.3 (95% confidence interval, 4.7 to 8.5) for fractionated plasma metanephrines and 58.9 (95% confidence interval, 22.1 to 156.9) for urinary total metanephrines and catecholamines. An adrenal pheochromocytoma was missed by urinary testing in two patients with familial syndromes and one asymptomatic patient with an incidentally discovered adrenal mass. An extra-adrenal paraganglioma was missed by plasma testing in one patient. In conclusion, measurements of 24-h urinary total metanephrines and catecholamines yield fewer false-positive results, an attribute preferred for testing low-risk patients, but fractionated plasma metanephrine measurements may be preferred in high-risk patients with familial endocrine syndromes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Measurement of plasma metanephrines or 24-hour urinary metanephrines is an effective screening test for patients in whom paraganglioma or pheochromocytoma is suspected.346”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [346]
Citations
Cites
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
Evidence-Based Medicine: How to Practice and Teach EBM
Sackett, D. L. (2000) · Cited by 5,950
Fundamentals of Biostatistics.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-4-873 · Cited by 4,573
Users' Guides to the Medical Literature
Jaeschke, R. (1994) · JAMA · doi:10.1001/jama.271.9.703 · Cited by 2,688
Self-citationSmithson, M. J. (2000) · SAGE Publications Ltd eBooks · doi:10.4135/9781446218525 · Cited by 1,871
Biochemical Diagnosis of Pheochromocytoma: Which Test Is Best?
Lenders, J. W. M., Pacak, K., Walther, M. M., Linehan, W. M., Mannelli, M., Friberg, P., Keiser, H. R., Goldstein, D. S., & Eisenhofer, G. (2002) · JAMA · doi:10.1001/jama.287.11.1427 · Cited by 1,134
Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma
Pacak, K., Linehan, W. M., Eisenhofer, G., Walther, M. M., & Goldstein, D. S. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-4-200102200-00016 · Cited by 618
MANAGEMENT APPROACHES TO ADRENAL INCIDENTALOMAS
Young, W. F. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70122-5 · Cited by 415
Self-citationA simple analysis for normetanephrine and metanephrine in urine
Plsano, J. J. (1960) · Clinica Chimica Acta · doi:10.1016/0009-8981(60)90146-7 · Cited by 349
Eisenhofer, G., Lenders, J. W. M., Linehan, W. M., Walther, M. M., Goldstein, D. S., & Keiser, H. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402404 · Cited by 346
Flagged first, then by citations
1 of the 24 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 502
Toledo, S. P. A., Lourenço, D. M., Sekiya, T., Lucón, A. M., Baena, M. E. D. S., de Castro, C. C., Bortolotto, L. A., Zerbini, M. C. N., Siqueira, S. A. C., Toledo, R. A., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2473 · Cited by 63
Pheochromocytomas and Paragangliomas
Tevosian, S. G., & Ghayee, H. K. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.08.006 · Cited by 66
Biochemical Diagnosis of Pheochromocytoma—Is it Time to Switch to Plasma-Free Metanephrines?
Eisenhofer, G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021913 · Cited by 63
Phaeochromocytoma and Paraganglioma
Gunawardane, P. T. K., & Grossman, A. B. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_76 · Cited by 62
Thakur, N., Gupta, D., Mandal, D., & Nagaiah, T. C. (2021) · Chemical Communications · doi:10.1039/d1cc05271c · Cited by 61
The Economic Implications of Three Biochemical Screening Algorithms for Pheochromocytoma
Sawka, A. M., Gafni, A., Thabane, L., & Young, W. F. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031127 · Cited by 59
Self-citationDiseases of the adrenal medulla
Fung, M. M., Viveros, O. H., & O’Connor, D. T. (2007) · Acta Physiologica · doi:10.1111/j.1748-1716.2007.01809.x · Cited by 58
Cardiovascular Manifestations of Pheochromocytoma
Gu, Y. W., Poste, J., Mehta, K., Schwarcz, M., & Weiss, I. A. (2017) · Cardiology in Review · doi:10.1097/crd.0000000000000141 · Cited by 58
Diagnosis and management of pheochromocytoma
Hodin, R. A., Lubitz, C. C., Phitayakorn, R., & Stephen, A. E. (2014) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2013.12.001 · Cited by 55
Pheochromocytoma and abdominal paraganglioma
Renard, J., Clerici, T., Licker, M. J., & Triponez, F. (2011) · Journal of Visceral Surgery · doi:10.1016/j.jviscsurg.2011.07.003 · Cited by 54
Kook, P. H., Boretti, F. S., Hersberger, M., Glaus, T. M., & Reusch, C. E. (2007) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2007.tb02980.x · Cited by 54
von Hippel-Lindau (VHL) Disease
Shehata, B. M., Stockwell, C. A., Castellano-Sanchez, A. A., Setzer, S. V., Schmotzer, C. L., & Robinson, H. B. (2008) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e31816f852e · Cited by 53
Roberts, N. B., Higgins, G., & Sargazi, M. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.017 · Cited by 51
Davidson, F. D. (2004) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563041201626 · Cited by 51
Kang, J.-S. (2012) · InTech eBooks · doi:10.5772/32085 · Cited by 50
Evaluation and management of adrenal incidentaloma
Bittner, J. G., & Brunt, L. M. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23161 · Cited by 49
Strosberg, J. (2013) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.11.009 · Cited by 48
Brown, H. A., Goldberg, P. A., Selter, J. G., Cabin, H. S., Marieb, N. J., Udelsman, R., & Setaro, J. F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1077 · Cited by 48
Hereditary pheochromocytoma and paraganglioma
Mazzaglia, P. J. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23157 · Cited by 47
Willemsen, J. J., Sweep, F. C. G. J., Lenders, J. W. M., & Ross, H. A. (2003) · Clinical Chemistry · doi:10.1373/clinchem.2003.023135 · Cited by 47
Taïeb, D., Sebag, F. A., Hubbard, J., MUNDLER, O., Henry, J.-F., & Conte‐Devolx, B. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02077.x · Cited by 47
Medical management of pheochromocytoma: Role of the endocrinologist
Garg, M., Kharb, S., Brar, K., Gundgurthi, A., & Mittal, R. (2011) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.86976 · Cited by 46
Clinical evaluation and treatment of phaeochromocytoma
Davison, A. S., Jones, D. M., Ruthven, S., Helliwell, T. R., & Shore, S. (2017) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563217739931 · Cited by 46
Young, W. F. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00016-x · Cited by 46
Self-citationDiagnosis of pheochromocytoma with special emphasis on MEN2 syndrome
Pacák, K., Eisenhofer, G., & Ilias, Ι. (2009) · HORMONES · doi:10.14310/horm.2002.1227 · Cited by 46
Brain, K. L., Kay, J. D., & Shine, B. S. F. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.070805 · Cited by 46
Sawka, A. M., Thabane, L., Gafni, A., Levine, M., & Young, W. F. (2005) · BMC Endocrine Disorders · doi:10.1186/1472-6823-5-1 · Cited by 45
Self-citationSane, T., Schalin‐Jäntti, C., & Raade, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1061 · Cited by 43
Procopiou, M., Finney, H., Akker, S. A., Chew, S. L., Drake, W. M., Burrin, J. M., & Grossman, A. B. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0172 · Cited by 43
Sarathi, V., Pandit, R., Patil, V. K., Lia, A. R., Bandgar, T., & Shah, N. S. (2012) · Endocrine Practice · doi:10.4158/ep12050.or · Cited by 43
Obstructive Sleep Apnea Presenting as Pseudopheochromocytoma: A Case Report
Hoy, L. J., Emery, M. J., Wedzicha, J. A., Davison, A. G., Chew, S. L., Monson, J. P., & Metcalfe, K. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031348 · Cited by 40
Endocrine hypertension: An overview on the current etiopathogenesis and management options
Thomas, R. M. (2015) · World Journal of Hypertension · doi:10.5494/wjh.v5.i2.14 · Cited by 40
Cystic adrenal lesions: Clinical and surgical management. The experience of a referral centre
Cavallaro, G., Crocetti, D., Paliotta, A., Gori, A. D., Tarallo, M., Letizia, C., & Toma, G. D. (2014) · International Journal of Surgery · doi:10.1016/j.ijsu.2014.11.023 · Cited by 42
Screening for Pheochromocytomas and Paragangliomas
Eisenhofer, G. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0246-y · Cited by 39
An analysis of the biochemical diagnosis of 66 pheochromocytomas
d’Herbomez, M., Forzy, G., Bauters, C. C., Tierny-Fontalirand, C., Pigny, P., Carnaille, B. M. L., Pattou, F. N., Wémeau, J.-L., & Rouaix, N. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0640 · Cited by 39
Mancia, G., Dominiczak, A. F., Fagard, R. H., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., Schmieder, R. E., Vahanian, A. S., Camm, A. J., Dean, V., et al. (2007) · Cited by 38
Daniel, E., Jones, R. N., Bull, M., & Newell-Price, J. D. C. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0595 · Cited by 36
Mullins, F., O’Shea, P. M., FitzGerald, R., & Tormey, W. P. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.742 · Cited by 36
Multiple endocrine neoplasia type 2
Pęczkowska, M., & Januszewicz, A. (2005) · Familial Cancer · doi:10.1007/s10689-005-0656-y · Cited by 36
Kim, H. J., Lee, J. I., Cho, Y. Y., Lee, S., Kim, H. J., Jung, B. C., Kim, S. W., Chung, J. H., Min, Y., Lee, M., et al. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej14-0384 · Cited by 34
Maia, A. L., Siqueira, D. R., Kulcsar, M. A. V., Tincani, Á. J., Mazeto, G. M. F. D. S., & Maciel, L. M. Z. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003427 · Cited by 34
Feocromocitoma: actualización diagnóstica y terapéutica
Oleaga, L., & Goñi, F. (2008) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(08)70669-7 · Cited by 33
Incidentally Discovered Adrenal Mass
Song, J. H., & Mayo-Smith, W. W. (2010) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2010.10.006 · Cited by 32
Advances in biochemical screening for phaeochromocytoma using biogenic amines.
Whiting, M. J., & Doogue, M. P. (2009) · PubMed Central · Cited by 32
Phaeochromocytoma: diagnostic challenges for biochemical screening and diagnosis
BARRON, J. L. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2009.071647 · Cited by 32
New and Emerging Syndromes due to Neuroendocrine Tumors
Vinik, A. I., & Gonzales, M. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.12.010 · Cited by 33
Pathophysiology, Evaluation, and Medical Management of Adrenal Disorders
Kutikov, A., Crispen, P. L., & Uzzo, R. G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00057-8 · Cited by 31
Evaluation of an Adrenal Incidentaloma
Jason, D. S., & Oltmann, S. C. (2019) · Surgical Clinics of North America · doi:10.1016/j.suc.2019.04.009 · Cited by 34
Jabbour, S. A., Davidovici, B. B., & Wolf, R. (2006) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2006.04.005 · Cited by 33
Christensen, T. T., Frystyk, J., & Poulsen, P. L. (2011) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2011.622410 · Cited by 31
Endocrine Hypertension: Then and Now
Young, W. F. (2010) · Endocrine Practice · doi:10.4158/ep10205.ra · Cited by 31
Self-citationGruber, L., Strajina, V., Bancos, I., Murad, M. H., Dy, B. M., Young, W. F., Farley, D. R., Lyden, M. L., Thompson, G. B., & McKenzie, T. J. (2020) · Gland Surgery · doi:10.21037/gs.2020.03.04 · Cited by 31
Self-citationTreatment of resistant hypertension
Taler, S. J. (2005) · Current Hypertension Reports · doi:10.1007/s11906-005-0064-6 · Cited by 31
High Plasma Levels of Human Chromogranin a and Adrenomedullin in Patients with Pheochromocytoma
Cotesta, D., Caliumi, C., Alò, P., Petramala, L., Reale, M. G., Masciangelo, R., Signore, A., Cianci, R., D'Erasmo, E., & Letizia, C. (2005) · Tumori Journal · doi:10.1177/030089160509100110 · Cited by 30
Low Sensitivity of Glucagon Provocative Testing for Diagnosis of Pheochromocytoma
Lenders, J. W. M., Pacák, K., Huynh, T., Sharabi, Y., Mannelli, M., Bratslavsky, G., Goldstein, D. S., Bornstein, S. R., & Eisenhofer, G. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1850 · Cited by 30
Godoy-Reyes, T. M., Costero, A. M., Gaviña, P., Martínez‐Máñez, R., & Sancenón, F. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2019.01.003 · Cited by 29
Chen, Y., Xiao, H., Zhou, X., Huang, X., Li, Y., Xiao, H., & Cao, X. (2017) · Endocrine Practice · doi:10.4158/ep171877.or · Cited by 32
Pathophysiology and Diagnosis of Disorders of the Adrenal Medulla: Focus on Pheochromocytoma
Lenders, J. W. M., & Eisenhofer, G. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130034 · Cited by 30
Ioachimescu, A. G., Remer, E. M., & Hamrahian, A. H. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.005 · Cited by 28
Diagnosis of a Pheochromocytoma
Westphal, S. A. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200501000-00004 · Cited by 28
Courses of Malignant Pheochromocytoma
Sisson, J. C., Shulkin, B. L., & Esfandiari, N. H. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.053 · Cited by 28
Gao, Y., Lu, H., Luo, Q., Chen, L., Ding, Y., & Zhu, R. (2008) · Clinical and Experimental Medicine · doi:10.1007/s10238-008-0162-2 · Cited by 27
Biochemical detection of phaeochromocytoma: why are we continuing to ignore the evidence?
Peaston, R., & Ball, S. G. (2008) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2007.007116 · Cited by 27
Liu, S., Song, A., Zhou, X., Kong, X., Li, W. A., Wang, Y., & Liu, Y. (2017) · Medicine · doi:10.1097/md.0000000000008535 · Cited by 26
Green, M., Ken‐Dror, G., Fluck, D. S., Sada, C., Sharma, P., Fry, C. H., & Han, T. S. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.14061 · Cited by 26
Havekes, B., van der Klaauw, A. A., Weiss, M. M., Jansen, J. C., van der Mey, A. G. L., Vriends, A. H. J. T., Bonsing, B. A., Romijn, J. A., & Corssmit, E. P. M. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0024 · Cited by 26
Sarathi, V., Pandit, R., Jagtap, V. S., Lila, A. R., Bandgar, T., Menon, P. S., Varthakavi, P., Raghavan, V. P., & Shah, N. S. (2011) · Endocrine Practice · doi:10.4158/ep11058.or · Cited by 26
Secondary Causes of Hypertension
Taler, S. J. (2008) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2008.06.001 · Cited by 28
Pheochromocytoma and functional paraganglioma
Roman, S. A. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200401000-00003 · Cited by 27
Treatment of Hypertension: A Review
Goit, L. N., & Yang, S. (2019) · Yangtze Medicine · doi:10.4236/ym.2019.32011 · Cited by 27
Turai, P. I., Nyírő, G., Butz, H., Patócs, A., & Igaz, P. (2021) · Cancers · doi:10.3390/cancers13071522 · Cited by 24
SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma
Perez, K. J., Jacene, H. A., Hornick, J. L., Ma, C., Vaz, N., Brais, L. K., Alexander, H., Baddoo, W., Astone, K., Esplin, E. D., et al. (2022) · Endocrine Related Cancer · doi:10.1530/erc-21-0392 · Cited by 24
Resistant hypertension: consensus document from the Korean society of hypertension
Park, S., Shin, J., Ihm, S., Kim, K., Kim, H., Kim, H. C., Lee, E. M., Lee, J. H., Ahn, S. Y., Cho, E. J., et al. (2023) · Clinical Hypertension · doi:10.1186/s40885-023-00255-4 · Cited by 26
The Mount Sinai Clinical Pathway for the Management of Pheochromocytoma
Galati, S.-J., Said, M., Gospin, R., Babić, N., Brown, K., Geer, E. B., Kostakoğlu, L., Krakoff, L. R., Leibowitz, A. B., Mehta, L., et al. (2014) · Endocrine Practice · doi:10.4158/ep14036.ra · Cited by 24
Chromogranin A assay in clinical practice
D’Herbomez, M., Cao, C. D., Vezzosi, D., Borzon-Chasot, F., & Baudin, É. (2010) · Annales d Endocrinologie · doi:10.1016/j.ando.2010.04.004 · Cited by 25
Pheochromocytoma crisis after a dexamethasone suppression test for adrenal incidentaloma
Yi, D. W., Kim, S. Y., Shin, D., Kang, Y. H., & Son, S. M. (2010) · Endocrine · doi:10.1007/s12020-009-9303-y · Cited by 24
Anesthetic Management of Pheochromocytoma
Woodrum, D. T., & Kheterpal, S. (2010) · World Journal of Endocrine Surgery · doi:10.5005/jp-journals-10002-1034 · Cited by 24
Evaluation of patients with adrenal incidentalomas
Kannan, S., Remer, E. M., & Hamrahian, A. H. (2013) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328360a43b · Cited by 23
Olson, S. W., Yoon, S. Y., Baker, T. P., Prince, L. K., Oliver, D. K., & Abbott, K. C. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0651 · Cited by 23
Kannan, S., Purysko, A. S., Faiman, C., Remer, E. M., Shah, L., Bena, J., SIPERSTEIN, A. E., Berber, E., Fergany, A., Bravo, E. L., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12420 · Cited by 23
WFUMB position paper on the management incidental findings: adrenal incidentaloma
Dietrich, C. F., Correas, J. M., Dong, Y., Nolsøe, C., Westerway, S. C., & Jenssen, C. (2019) · ULTRASONOGRAPHY · doi:10.14366/usg.19029 · Cited by 21
Diagnosis, localization and treatment of pheochromocytoma in MEN 2 syndrome.
Ilias, Ι., & Pacák, K. (2009) · PubMed · Cited by 22
Management of the Incidental Adrenal Mass
Thomas, A. Z., Blute, M. L., Seitz, C., Habra, M. A., & Karam, J. A. (2016) · European Urology Focus · doi:10.1016/j.euf.2015.12.006 · Cited by 22
Phaeochromocytoma: State-of-the-art
Donckier, J. E., & Michel, L. A. (2010) · Acta chirurgica Belgica · doi:10.1080/00015458.2010.11680587 · Cited by 21
Proficiency test of plasma free and total metanephrines: report from a study group
Pillai, D. N., Ross, H. A., Kratzsch, J., Pedrosa, W., Kema, I. P., Hoad, K., Rouaix, N., Fathi, M., Nader, H., Mathian, B., et al. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.162 · Cited by 21
Incidentally discovered masses in hypertensive patients
Cicala, M. V., Sartorato, P., & Mantero, F. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.07.009 · Cited by 21
Zuo, M. Z., Zhen, Q., Zhang, X., Zou, W., Yang, X., Tian, G., Shi, Z., Li, Q., & Ding, M. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.12.026 · Cited by 21
Endocrine emergencies in anesthesia
Robles, C. R. F., Carr, Z. J., & Oprea, A. D. (2021) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000986 · Cited by 20
Advances in metanephrine testing for the diagnosis of pheochromocytoma
Singh, R. (2004) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.01.015 · Cited by 20
Self-citationPlasma‐free vs deconjugated metanephrines for diagnosis of phaeochromocytoma
Pamporaki, C., Därr, R., Bursztyn, M., Glöckner, S., Bornstein, S. R., Lenders, J. W. M., Pacák, K., Krinner, A., & Eisenhofer, G. (2013) · Clinical Endocrinology · doi:10.1111/cen.12191 · Cited by 19
Cerqueira, A., Seco, T., Costa, A., Tavares, M. M. A., & Cotter, J. (2020) · Cureus · doi:10.7759/cureus.7969 · Cited by 19
Pheochromocytoma: pitfalls in the biochemical evaluation
Dobri, G. A., Bravo, E. L., & Hamrahian, A. H. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.887985 · Cited by 19
Hattangadi, S. B., & Balagopal, N. T. (2016) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-016-0597-y · Cited by 21
Case 8-2018: A 55-Year-Old Woman with Shock and Labile Blood Pressure
Loscalzo, J., Roy, N., Shah, R. V., Tsai, J. N., Cahalane, A. M., Steiner, J., & Stone, J. R. (2018) · New England Journal of Medicine · doi:10.1056/nejmcpc1712225 · Cited by 18
Secondary hypertension: a condition not to be missed
Sukor, N. (2011) · Postgraduate Medical Journal · doi:10.1136/pgmj.2011.118661 · Cited by 18
Shirodkar, M. A., & Jabbour, S. A. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01831.x · Cited by 18
Diagnosing endocrine hypertension: a practical approach
Yang, J., Shen, J., & Fuller, P. J. (2017) · Nephrology · doi:10.1111/nep.13078 · Cited by 19
Falsely elevated plasma metanephrine in patients taking midodrine
Emms, H., Farah, G. M., Shine, B. S. F., Boot, C., Toole, B. J., McFadden, M., Lam, L., Ou, Z., Woollard, G. A., Madhavaram, H., et al. (2018) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563218755817 · Cited by 18
Multiple Endocrine Neoplasia Type 2: Clinical Manifestations and Management
Traugott, A. L., & Moley, J. F. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0857-5_18 · Cited by 18
Makino, S., Iwata, M., Fujiwara, M., Ike, S., & Tateyama, H. (2006) · Endocrine Journal · doi:10.1507/endocrj.k05-169 · Cited by 18
Metadata
- Authors
- Sawka, A. M., Jaeschke, R., Singh, R. J., & Young, W. F.
- Affiliations
- Mayo Clinic (US)
- St. Joseph’s Healthcare Hamilton (CA)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-02
- Volume
- 88
- Issue
- 2
- Pages
- 553-558
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1979170245
- Cited by
- 503
- References
- 24
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 10 · 2023: 8 · 2022: 21 · 2021: 18 · 2020: 14 · 2019: 17 · 2018: 10 · 2017: 24 · 2016: 21 · 2015: 19 · 2014: 29 · 2013: 27 · 2012: 22
- FWCI
- 25.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mayo Clinic
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- pheochromocytoma, catecholamines, sensitivity and specificity, likelihood ratios, paraganglioma, adrenal incidentaloma, false positives
- MeSH terms
- Adolescent, Adrenal Gland Neoplasms, Adult, Aged, Aged, 80 and over, Catecholamines, Child, Female, Head and Neck Neoplasms, Humans, Male, Metanephrine, Middle Aged, Outpatients, Paraganglioma, Pheochromocytoma, Sensitivity and Specificity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
